Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03281772 · ClinicalTrials.gov registry record
Uncontrolled Hypertension Management (TEAM-HTN)
A clinical trial, sponsored by Madigan Army Medical Center.
- Terminated
- Registry status
- 70
- Enrollment target
NCT03281772: Clinical Trial study, sponsored by Madigan Army Medical Center.
NCT03281772 is a clinical trial that was terminated before completion, run by Madigan Army Medical Center. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03281772 was terminated before completion, sponsored by Madigan Army Medical Center.
- TERMINATED
- Registry status
- 70 participants
- Enrollment target
Study Summary
Current guideline directed medical therapies (GDMT) for hypertension (HTN) endorse a trial and error approach based on drug class. This pilot study will evaluate the efficacy of a Clinical Decision Support (CDS) program to assist providers with delivering a more personalized approach using individual renin-aldosterone levels and the mechanism of action of medications included in GDMT recommendations. The overarching goal is to achieve HTN control rates above the 2014 National Health and Nutrition Examination Survey reported rate of 53% in a timely fashion, by individualizing medication management, thereby reducing the patient risk of stroke, heart and renal disease, and other devastating HTN-related outcomes.
Primary Outcome
Percent of systolic and diastolic blood pressure readings within patient-specific target goals averaged in 10-day cycles at least 70% of the time.
Interventions
- OTHER Clinical Decision Software - provider portal
- OTHER Clinical Decision Software - patient portal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2017-01-24 |
| Est. Completion | 2018-07-31 |
Why NCT03281772 stopped before completion
NCT03281772 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Clinical Decision Software - provider portal is the first listed.
NCT03281772 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03281772 about?
NCT03281772 is a clinical study titled "Uncontrolled Hypertension Management (TEAM-HTN)". Current guideline directed medical therapies (GDMT) for hypertension (HTN) endorse a trial and error approach based on drug class. This pilot study will evaluate the efficacy of a Clinical Decision Support (CDS) program to assist providers with delivering a more personalized approach using individua...
What is the current status of trial NCT03281772?
This trial is currently terminated. The enrollment target is 70 participants. The study started on 2017-01-24. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT03281772?
The interventions under investigation include: Clinical Decision Software - provider portal (OTHER), Clinical Decision Software - patient portal (OTHER).
Who is sponsoring clinical trial NCT03281772?
This trial is sponsored by Madigan Army Medical Center, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI